Skip to main content

Sodium Acetate Injection Shortage

Last Updated: February 23, 2017
Status: Resolved

Products Affected - Description
    • Sodium acetate injection, American Regent, 2 mEq/mL, 20 mL vial, 25 count, NDC 00517-2096-25
    • Sodium acetate injection, American Regent, 4 mEq/mL, 50 mL vial, 25 count, NDC 00517-5023-25
Reason for the Shortage
    • American Regent has sodium acetate injection on long-term back order due to manufacturing delays. It is unclear if and when they will return to market.
    • Fresenius Kabi has sodium acetate injection available.
    • Pfizer has sodium acetate injection available.
Available Products
    • Sodium acetate injection, Fresenius Kabi, 4 mEq/mL, 100 mL vial, 25 count, NDC 63323-0032-61
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 100 mL vial, 25 count, NDC 00409-3299-06
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-7299-73
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3299-05

Estimated Resupply Dates

    • American Regent has sodium acetate 2 mEq/mL 20 mL vials and 4 mEq/mL 50 mL vials on long-term back order and the company cannot estimate a release date.
    • All other marketed presentations are available.

Updated

Updated February 23, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 30, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.